UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction

JACC. Heart failure, 2016-06, Vol.4 (6), p.464-472

2016

Volltextzugriff (PDF)

Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations

JACC. Heart failure, 2020-12, Vol.8 (12), p.1038-1049

2020

Volltextzugriff (PDF)

Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy

JACC. Heart failure, 2015-11, Vol.3 (11), p.906-916

2015

Volltextzugriff (PDF)

Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes

JACC. Heart failure, 2016-12, Vol.4 (12), p.935-946

2016

Volltextzugriff (PDF)

Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction

JACC. Heart failure, 2017-07, Vol.5 (7), p.483-493

2017

Volltextzugriff (PDF)

Race-Based Analyses in Heart Failure Clinical Trials: What Makes Them Informative?

JACC. Heart failure, 2023-05, Vol.11 (5), p.580-582

2023

Volltextzugriff (PDF)

Sociodemographic Disparities in the GDMT Usage

JACC. Heart failure, 2023-02, Vol.11 (2), p.173-175

2023

Volltextzugriff (PDF)

Association of Arterial Pulse Pressure With Long-Term Clinical Outcomes in Patients With Heart Failure

JACC. Heart failure, 2016, Vol.4 (1), p.42-49

2016

Volltextzugriff (PDF)

Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy

JACC. Heart failure, 2017-05, Vol.5 (5), p.388-392

2017

Volltextzugriff (PDF)

Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project

JACC. Heart failure, 2016-12, Vol.4 (12), p.911-919

2016

Volltextzugriff (PDF)

Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis

JACC. Heart failure, 2016-04, Vol.4 (4), p.237-248

2016

Volltextzugriff (PDF)

Heart Transplantation: An In-Depth Survival Analysis

JACC. Heart failure, 2020-07, Vol.8 (7), p.557-568

2020

Volltextzugriff (PDF)

The Uncertainty of Sodium Restriction in Heart Failure: We Can Do Better Than This

JACC. Heart failure, 2016-01, Vol.4 (1), p.39-41

Yancy, Clyde W.

2016

Volltextzugriff (PDF)

The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper

JACC. Heart failure, 2020-01, Vol.8 (1), p.1-11

2020

Volltextzugriff (PDF)

Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF)

JACC. Heart failure, 2017-04, Vol.5 (4), p.305

2017

Volltextzugriff (PDF)

Hypertension, Obesity, Diabetes, and Heart Failure–Free Survival

JACC. Heart failure, 2016-12, Vol.4 (12), p.911-919

2016

Volltextzugriff (PDF)

Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure

JACC. Heart failure, 2016-04, Vol.4 (4), p.237-248

2016

Volltextzugriff (PDF)

Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

JACC. Heart failure, 2021-12, Vol.9 (12), p.876-886

2021

Volltextzugriff (PDF)

Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States

JACC. Heart failure, 2023-02, Vol.11 (2), p.211-223

2023

Volltextzugriff (PDF)

Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes

JACC. Heart failure, 2022-03, Vol.10 (3), p.198-210

2022

Volltextzugriff (PDF)

Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure

JACC. Heart failure, 2024-08, Vol.12 (8), p.1365-1377

2024

Volltextzugriff (PDF)

Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction

JACC. Heart failure, 2023-08, Vol.11 (8 Pt 1), p.918-929

2023

Volltextzugriff (PDF)

Heart Failure Risk Among African-American Women With an ICAM1 Missense Variant

JACC. Heart failure, 2024-09, Vol.12 (9), p.1614-1624

2024

Volltextzugriff (PDF)

Failure Is Not an Option: Optimizing Care for Heart Failure Patients at the End of Life

JACC. Heart failure, 2019-07, Vol.7 (7), p.558-560

2019

Volltextzugriff (PDF)

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF

JACC. Heart failure, 2019-11, Vol.7 (11), p.980-992

2019

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Zeitschrift / SerieJacc. Heart Failure

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(50)
MEDLINE
(29)

Zeitschrift / Serie

Jacc: Heart Failure
(5)

Menü

Weitere Dienste

Einstellungen

Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction

Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations

Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy

Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes

Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction

Race-Based Analyses in Heart Failure Clinical Trials: What Makes Them Informative?

Sociodemographic Disparities in the GDMT Usage

Association of Arterial Pulse Pressure With Long-Term Clinical Outcomes in Patients With Heart Failure

Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy

Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project

Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis

Heart Transplantation: An In-Depth Survival Analysis

The Uncertainty of Sodium Restriction in Heart Failure: We Can Do Better Than This

The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper

Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF)

Hypertension, Obesity, Diabetes, and Heart Failure–Free Survival

Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure

Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States

Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes

Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure

Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction

Heart Failure Risk Among African-American Women With an ICAM1 Missense Variant

Failure Is Not an Option: Optimizing Care for Heart Failure Patients at the End of Life

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF

Aktive Filter

Suchergebnisse filtern